Markets
← Back to Stocks
ABT
ABBOTT LABORATORIES
Health Care · Health Care Equipment
$107.19
-1.12%
Vol: 0.3M
Araverus Market Read
Thursday, March 19, 2026
Strong Buy consensus lifts Abbott despite 0.86% after-hours decline
Abbott Laboratories declined 0.86% in after-hours to $109.00 and 0.18% in pre-market to $109.75. Recent results showed 4.4% revenue growth but missed consensus estimates, though the board declared a quarterly dividend of $0.63. According to 16 analysts, average rating is Strong Buy with 12-month price target of $139.38 (24.73% upside).
Price 50d 200d
Previous Market Reads
2 of 2 days↑
Sector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| LLYELI | $916.83 | -0.13% | -11.4% | 21.8x | 0.43 | $821.2B |
| JNJJOHNSON | $237.56 | +0.16% | -1.8% | 18.9x | 0.33 | $572.6B |
| ABBVABBVIE | $206.31 | -0.97% | -11.4% | 12.8x | 0.33 | $364.6B |
| MRKMERCK | $114.17 | -0.29% | -5.4% | 11.7x | 0.26 | $282.3B |
| UNHUNITEDHEALTH | $280.37 | -1.29% | -2.2% | 14.1x | 0.38 | $254.5B |
| AMGNAMGEN | $349.90 | -0.42% | -6.3% | 15.0x | 0.42 | $188.6B |
| ABTABBOTT | $107.19 | -1.12% | -4.5% | 17.2x | 0.74 | $186.3B |
| GILDGILEAD | $141.06 | -0.17% | -8.6% | 14.7x | 0.37 | $175.2B |
| TMOTHERMO | $470.21 | +1.18% | -6.2% | 17.5x | 0.97 | $174.7B |
Fundamentals
Market Cap$186.3B
P/E (TTM)28.8
Forward P/E17.2
Beta0.74
Div Yield232.00%
Prev Close$108.40
RSI (14-Day)
28Oversold
0305070100
52-Week Range
$105.27$107.19$139.06
From High-22.9%
From Low+1.8%
Moving Averages
50d SMA
$113.46-5.5%
200d SMA
$124.95-14.2%
Price below 200d MA — bearish structure.
Returns
1W
-0.9%
1M
-5.4%
3M
-15.1%
6M
-19.4%
1Y
-13.5%
YTD
-13.3%
Volume
Today330K
20d Avg8.7M
Ratio0.04x